Illumina

$306.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.90 (+1.62%) As of 3:57 PM UTC today

Why Robinhood?

You can buy or sell Illumina and other stocks, options, and ETFs commission-free!

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA. The listed name for ILMN is Illumina, Inc. Common Stock.

CEO
Francis A. deSouza
Employees
7,700
Headquarters
San Diego, California
Founded
1998
Market Cap
44.63B
Price-Earnings Ratio
69.78
Dividend Yield
Average Volume
1.28M
High Today
$307.87
Low Today
$303.26
Open Price
$304.81
Volume
375.04K
52 Week High
$404.20
52 Week Low
$196.78

Collections

ILMN Earnings

$0.00
$0.64
$1.29
$1.93
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Jan 27, After Hours

You May Also Like